ATE421336T1 - Medizinische zusammensetzungen mit cholesterin erniedrigender wirkung - Google Patents

Medizinische zusammensetzungen mit cholesterin erniedrigender wirkung

Info

Publication number
ATE421336T1
ATE421336T1 AT98933883T AT98933883T ATE421336T1 AT E421336 T1 ATE421336 T1 AT E421336T1 AT 98933883 T AT98933883 T AT 98933883T AT 98933883 T AT98933883 T AT 98933883T AT E421336 T1 ATE421336 T1 AT E421336T1
Authority
AT
Austria
Prior art keywords
effect
ppar
cholesterol
delta
activating
Prior art date
Application number
AT98933883T
Other languages
English (en)
Inventor
Teruhiko Shimokawa
Satomi Nishijima
Koyo Matsuda
Yuichi Iizumi
Seiichi Hashimoto
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16387713&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE421336(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ATE421336T1 publication Critical patent/ATE421336T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
AT98933883T 1997-07-24 1998-07-22 Medizinische zusammensetzungen mit cholesterin erniedrigender wirkung ATE421336T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19823297 1997-07-24

Publications (1)

Publication Number Publication Date
ATE421336T1 true ATE421336T1 (de) 2009-02-15

Family

ID=16387713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98933883T ATE421336T1 (de) 1997-07-24 1998-07-22 Medizinische zusammensetzungen mit cholesterin erniedrigender wirkung

Country Status (9)

Country Link
US (1) US6300364B1 (de)
EP (1) EP1023907B1 (de)
JP (1) JP4427825B2 (de)
AT (1) ATE421336T1 (de)
AU (1) AU8355998A (de)
CA (1) CA2295930C (de)
DE (1) DE69840510D1 (de)
ES (1) ES2320181T3 (de)
WO (1) WO1999004815A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0103714A3 (en) 1998-05-11 2003-05-28 Takeda Pharmaceutical Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity, medicaments containing them and their use
GB9914977D0 (en) * 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
GB9917405D0 (en) * 1999-07-23 1999-09-22 Univ Dundee Methods of treatment and drug screening methods
TWI262185B (en) 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
AU1303301A (en) * 1999-11-10 2001-06-06 Takeda Chemical Industries Ltd. Body weight gain inhibitors
AU2001277723A1 (en) 2000-08-11 2002-02-25 Nippon Chemiphar Co., Ltd. Ppardelta activators
GB0024361D0 (en) * 2000-10-05 2000-11-22 Glaxo Group Ltd Medicaments
GB0024362D0 (en) * 2000-10-05 2000-11-22 Glaxo Group Ltd Medicaments
EP1911462A3 (de) 2001-01-26 2011-11-30 Schering Corporation Zusammensetzungen enthaltend einen Sterolabsorptionshemmer
WO2002070011A2 (en) * 2001-02-02 2002-09-12 Smithkline Beecham Corporation Treatment of ppar mediated diseases
EP1375484A4 (de) 2001-03-28 2009-08-05 Eisai R&D Man Co Ltd Carbonsäuren
WO2002081428A1 (fr) 2001-03-30 2002-10-17 Eisai Co., Ltd. Compose de benzene et sel de ce compose
TWI311133B (en) 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
US20040077689A1 (en) * 2001-04-25 2004-04-22 Yasuo Sugiyama Abc expression promoters
JPWO2002098840A1 (ja) 2001-06-04 2004-09-16 エーザイ株式会社 カルボン酸誘導体及びその塩もしくはそのエステルからなる医薬
US20040242459A1 (en) * 2001-06-11 2004-12-02 Forrest Michael J Method for treating inflammatory diseases by administering a ppar-delta agonist
KR100912852B1 (ko) 2001-07-17 2009-08-18 데이진 가부시키가이샤 ＰＰＡＲ δ활성화 작용을 측정하는 것을 특징으로 하는물질의 선택방법 및 약제
JP4870464B2 (ja) * 2001-07-17 2012-02-08 帝人株式会社 ＰＰＡＲδ活性化作用を測定することを特徴とする物質の選択方法及び薬剤
CA2457054C (en) * 2001-08-10 2011-10-11 Nippon Chemiphar Co., Ltd. Activator of peroxisome proliferator-activated receptor .delta.
WO2003016265A1 (fr) 2001-08-17 2003-02-27 Eisai Co., Ltd. Compose cyclique et agoniste du recepteur ppar
JP4269052B2 (ja) 2001-09-14 2009-05-27 アムジエン・インコーポレーテツド 連結ビアリール化合物
CA2463569C (en) * 2001-10-12 2012-05-15 Nippon Chemiphar Co., Ltd. Activator for peroxisome proliferator-activated receptor .delta.
US7091245B2 (en) 2002-09-05 2006-08-15 Novo Novdisk A/S Compounds, their preparation and use
US7129268B2 (en) 2002-10-28 2006-10-31 Novo Nordisk A/S Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
BR0315683A (pt) 2002-10-28 2005-08-30 Novo Nordisk As Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento e/ou prevenção de condições mediadas por receptores nucleares e para o tratamento e/ou prevenção do diabete do tipo i, diabete do tipo ii, tolerância à glicose prejudicada, resistência à insulina ou obesidade
US20050080115A1 (en) 2002-10-28 2005-04-14 Lone Jeppesen Novel compounds, their preparation and use
CN1708479A (zh) 2002-10-28 2005-12-14 诺沃挪第克公司 可用于治疗ppar所介导的疾病的新颖化合物
WO2004093910A1 (ja) * 2003-04-22 2004-11-04 Astellas Pharma Inc. ＰＰＡＲδアゴニストによる脳神経変性疾患治療剤
US7301050B2 (en) 2003-09-19 2007-11-27 Janssen Pharmaceutical N.V. 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
US7968723B2 (en) 2004-05-05 2011-06-28 High Point Pharmaceuticals, Llc Compounds, their preparation and use
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
EP1751120A4 (de) 2004-05-25 2010-05-05 Metabolex Inc Substituierte triazole als ppar-modulatoren und herstellungsverfahren dafür
US8111617B2 (en) * 2004-08-13 2012-02-07 Broadcom Corporation Multiple independent pathway communications
MY147518A (en) * 2004-09-15 2012-12-31 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MY145712A (en) * 2004-09-15 2012-03-30 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JP2008538351A (ja) 2005-03-21 2008-10-23 メタボレックス インコーポレーティッド 癌を含むＰＰＡＲγ反応性疾患の処置または予防における浮腫を回避するための方法
ATE529404T1 (de) 2005-06-30 2011-11-15 High Point Pharmaceuticals Llc Phenoxyessigsäuren als ppar-delta-aktivatoren
AU2006282403B2 (en) * 2005-08-26 2011-07-07 Institute Of Medicinal Molecular Design, Inc. Derivative having PPAR agonistic activity
JO3006B1 (ar) 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
CN103224477A (zh) 2005-12-22 2013-07-31 高点制药有限责任公司 作为PPAR-δ活化剂的苯氧基乙酸
JP2009529512A (ja) 2006-03-09 2009-08-20 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー 新規な化合物、それらの製造法、及び使用法
CN102643248A (zh) * 2006-04-18 2012-08-22 日本化学医药株式会社 过氧化物酶体增殖剂激活受体δ的激活剂
UY30288A1 (es) 2006-04-18 2007-08-31 Janssen Pharmaceutica Nv Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol
AU2007292874B2 (en) 2006-09-08 2013-11-21 Rhode Island Hospital Treatment, prevention, and reversal of alcohol-induced liver disease
US9308198B2 (en) 2006-09-08 2016-04-12 Rhode Island Hospital Treatment, prevention, and reversal of alcohol-induced brain disease
EP2155769B1 (de) 2007-05-04 2012-06-27 Katholieke Universiteit Leuven KU Leuven Research & Development Schutz gegen gewebedegeneration
MX2010011252A (es) * 2008-04-15 2010-11-30 Nippon Chemiphar Co Activador para el receptor activado por el proliferador de peroxisoma.
KR20120099378A (ko) * 2009-08-14 2012-09-10 닛뽕 케미파 가부시키가이샤 염증 또는 에너지 대사/생산 관련 질환의 치료 또는 예방을 위한 ｐｐａｒ 델타 리간드의 용도
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
EP3043789B1 (de) 2013-09-09 2020-07-08 vTv Therapeutics LLC Verwendung von ppar-delta-agonisten zur behandlung von muskelatrophie
WO2023147309A1 (en) 2022-01-25 2023-08-03 Reneo Pharmaceuticals, Inc. Use of ppar-delta agonists in the treatment of disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA858493B (en) 1984-11-12 1986-07-30 Yamanouchi Pharma Co Ltd Heterocyclic compounds and process of producing them
JPS61268657A (ja) 1985-05-23 1986-11-28 Takeda Chem Ind Ltd フエニル酢酸誘導体およびその製造法
JPH0788426B2 (ja) 1986-07-30 1995-09-27 住友ベークライト株式会社 耐熱性樹脂の製造方法
JPH02215717A (ja) 1989-02-14 1990-08-28 Yamanouchi Pharmaceut Co Ltd 血清脂質低下剤
CZ281130B6 (cs) 1993-06-18 1996-06-12 Galena, A.S. Deriváty 4-alkyloxy-3-propyl-2-hydroxyacetofenonu
WO1996001317A2 (en) 1994-07-01 1996-01-18 The Salk Institute For Biological Studies Mammalian peroxisome proliferator-activated receptors and uses thereof
GB2292885A (en) 1994-09-08 1996-03-13 Merck & Co Inc Method of treating hyperlipidemia
AU725998B2 (en) 1995-09-18 2000-10-26 Eisai R&D Management Co., Ltd. Treating NIDDM with RXR agonists
EP0788353A1 (de) * 1995-09-18 1997-08-13 Ligand Pharmaceuticals, Inc. Ppar gamma antagonisten zur behandlung der fettleibigkeit
EP1011651B1 (de) 1996-02-02 2005-04-27 Merck & Co., Inc. Verfahren zur behandlung von diabetes und verwandter krankheitszustände.
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents

Also Published As

Publication number Publication date
AU8355998A (en) 1999-02-16
CA2295930C (en) 2010-12-14
EP1023907A4 (de) 2001-02-21
WO1999004815A1 (fr) 1999-02-04
EP1023907B1 (de) 2009-01-21
EP1023907A1 (de) 2000-08-02
CA2295930A1 (en) 1999-02-04
US6300364B1 (en) 2001-10-09
DE69840510D1 (de) 2009-03-12
ES2320181T3 (es) 2009-05-19
JP4427825B2 (ja) 2010-03-10

Similar Documents

Publication Publication Date Title
ATE421336T1 (de) Medizinische zusammensetzungen mit cholesterin erniedrigender wirkung
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9300761A (pt) Composto,processo para a sua preparacao,aplicacao desse composto,preparacao farmaceutica e processo para a sua preparacao
BR9104533A (pt) Composicao antimicrobiana,derivados,processo para sua preparacao,medicamentos,composicoes pesticidas,utilizacao de derivados,processos para o combate de pragas e para a preparacao de composicoes
NO950297D0 (no) Prolinamidderivater
ITRM920361A0 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
NO921835D0 (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
ATE213387T1 (de) N-arylhydrazinderivate als insektizide und akarizide mittel
ES2052065T3 (es) Formulacion dispersable.
ATE108437T1 (de) Substituierte diaminophthalimide und analoga.
PT102145A (pt) Derivados de piperazina acetamida, processo para a sua preparacao e composicoes farmaceuticas.
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
NO960632L (no) Nye bis-naftalimider for behandling av kreft
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
DE69128630D1 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
BR9807330A (pt) Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo
HUP0004900A2 (hu) Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények
DK0709372T3 (da) N-Arylthiohydrazonderivater som insecticide og acaricide midler
EP1214939A4 (de) Ppar-alpha und ppar-gamma-hemmer
FI923662A (fi) Terapeutiska medel
DK93091A (da) Laegemidler til behandling af toxoplasmose
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties